Pages

October 6, 2023

Take period pains seriously to improve women’s quality of life

        Women should not normalize extreme period pain as this could be a sign of endometriosis.

        Together with its partners from international and local medical societies, Bayer supported the 2023 Asian Congress on Endometriosis this 2023 held at Marriott Manila Hotel to help healthcare providers (HCPs) address delayed diagnosis and treatment of endometriosis.

        Bayer advocates for more Conversations of Care around women’s health and encourages more Filipino women to seek free OB-GYNE consultations in selected partner drugstores from September to October 2023.

Manila, Philippines – Over 10% or 190 million women and girls of reproductive age globally are affected by severe pain associated with endometriosis, a painful gynecological disease in which the lining of the uterus grows outside of it, and this burden affects more women in Asia. Yet misconceptions about endometriosis, such as extreme period pain, are something women still view as part of the norm– resulting in prolonged pain and delayed treatment.

Bayer Philippines, in collaboration with its partners from the Society of Endometriosis and Uterine Disorders (SEUD) and the Philippine Society for Reproductive Medicine (PRSM), calls for more conversations of care and action to eliminate pain associated with endometriosis by supporting the Asian Congress on Endometriosis (ACE) in the Philippines this year.

OB-GYNE and Asian Congress on Endometriosis 2023 Congress President Dr. Angela Aguilar shared during the Endometriosis Masterclass that prevalence rates of the disease are reportedly higher in Asia compared to other continents.

According to Dr. Angela Aguilar, OB-GYNE and ACE 2023 Congress President, these misconceptions create more barriers on why women do not consult their doctors. “There is an information gap associated with endometriosis and women continue to suffer in silence brought about by debilitating pain,” she said. “This affects their daily activities, their productivity suffers at work and school– diminishing their quality of life.”

Importance of Early Diagnosis

“Endometriosis sometimes takes several years to be diagnosed, but with the Asia Consensus guidelines, it allows us to help HCPs tackle endometriosis by improving diagnosis and treatment standards of the condition in Asia, enabling them to create the best outcomes for their patients,” said Dr. Catherine Donovan, Head of Medical Affairs Asia-Pacific, Bayer Pharmaceuticals Asia-Pacific.

During the Asian Congress on Endometriosis 2023, Dr. Catherine Donovan, Head of Medical Affairs Asia-Pacific, Bayer Pharmaceuticals Asia-Pacific, emphasized that HCPs should initiate conversations of care among their patients for early detection of endometriosis.

The consensus guideline “Clinical Diagnosis and Early Medical Management for Endometriosis: Consensus for Asia” details the recommended practices for caring for women with endometriosis. It emphasizes the role of non-invasive procedures in early diagnosis and treatment to allow for patient-centered care.

In an endometriosis masterclass held at the Marriott Manila Hotel, Bayer emphasized the importance of creating safe spaces for conversations on endometriosis to provide a multidimensional approach on patient care.

Seek medical help

Women should realize that pelvic pain accompanying periods are not normal. They should seek help to evaluate the cause of this pain. According to Dr. Aguilar, patients may undergo pelvic examination and imaging as appropriate. Pelvic pain may be due to endometriosis and experts in the field can discern if this is present.

Endometriosis is a chronic condition, but there are ways of managing the pain and preserving the woman's fertility as long as it is discovered early and handled competently. “Many patients respond well to medication and go back to their lifestyle with little to no pain”, she added.

Working with multi sectoral partners and joining in the ACE 2023 in the Philippines is part of Bayer’s core commitment in advancing innovative solutions for women’s healthcare. With its recently launched Bayer For Her: Conversations of Care campaign, Bayer aims to raise awareness on women’s health by normalizing discussions on what is considered taboo topics in the country such as menstrual issues and endometriosis.

To help more women make informed choices about their own bodies and seek expert advice on reproductive health, Bayer For Her has an ongoing series of free pop-up consultation clinics at selected Mercury Drug, Southstar Drug, Rose Pharmacy, and Watsons until October 2023.

For more information about the free consultation clinics or signs and symptoms of endometriosis, visit Bayer Philippines’ Ask Mara Facebook page.

--------------------------------------

References

World Health Organization. Endometriosis. Available at: https://www.who.int/news-room/fact-sheets/detail/endometriosis#:~:text=Endometriosis%20often%20causes%20severe%20pain,don't%20have%20any%20symptoms.

 Chih-Feng Yen. 2019. Epidemiologic Factors Associated with Endometriosis in East Asia. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367920/

BioSpectrum. 2022. Bayer unveils guideline for diagnosis and early management for Endometriosis in Asia. Available at: https://www.biospectrumasia.com/influencers/54/19789/bayer-unveils-guideline-for-diagnosis-and-early-management-for-endometriosis-in-asia.html

 

------------------------------- 

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2022, the Group employed around 101,000 people and had sales of 50.7 billion euros. R&D expenses before special items amounted to 6.2 billion euros. For more information, go to www.bayer.com.

 ----------------------------

About Endometriosis

According to the World Health Organization, endometriosis is a chronic disease associated with life-impacting pain during periods, sexual intercourse, bowel movements, and/or urination. Other symptoms include fatigue, nausea, and anxiety.

 

No comments:

Post a Comment